News VIRTUAL SBIR and OTHER NON-DILUTIVE FUNDING SOURCES WORKSHOP with 1:1 PARTNERING – March 17-19, 2021 (2) Don’t miss a unique opportunity to discuss your biohealth technology innovation directly…Super UserFebruary 22, 2021
News VIRTUAL SBIR and OTHER NON-DILUTIVE FUNDING SOURCES WORKSHOP with 1:1 PARTNERING – March 17-18, 2021 Don’t miss a unique opportunity to discuss your biohealth technology innovation directly…Super UserFebruary 22, 2021
News 2/28 Deadline to Apply for $ (oncology innovation)… for The Rockville-based National Foundation for Cancer Research is accepting applications through…Super UserFebruary 22, 2021
News Salisbury Award for Entrepreneurial Translational Research – NFCR The National Foundation for Cancer Research is proud to present the Salisbury…Super UserFebruary 22, 2021
News Cartesian Therapeutics Initiates Phase 2 Clinical Trial of First RNA-Engineered Cell Therapy for Frontline Cancer – Cartesian Gaithersburg, MD, Feb. 22, 2021 – Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical…Super UserFebruary 22, 2021
News Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico | Novavax Inc. – IR Site GAITHERSBURG, Md., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX),…Super UserFebruary 22, 2021
News Eyedea Medical Joins Baltimore’s LaunchPort™ Medtech Venture Center The LaunchPort™ announced today that Eyedea Medical (https://www.eyedeamedical.com/) joined the Venture Center…Super UserFebruary 22, 2021
News John Mumm, CEO of Deka BioSciences, joins Rich Bendis on BioTalk Deka BioSciences CEO, John Mumm, CEO of Deka BioSciences, virtually guests on…Super UserFebruary 22, 2021
News Maryland Today | Pandemic Fighter’s Priorities One of the nation’s leading scientists in the desperate campaign to develop…Super UserFebruary 22, 2021
News 5 Questions with Paul Nolde, Fund Manager/Managing Director, Riverflow Growth Fund · BioBuzz “5 Questions With…” is a weekly BioBuzz series where we reach out…Super UserFebruary 22, 2021